Search for: "Teva Pharmaceuticals USA Inc"
Results 1 - 20
of 470
Sorted by Relevance
|
Sort by Date
1 Apr 2019, 9:59 pm
Teva Pharmaceuticals USA, Inc., the Federal Circuit reversed a decision by the U.S. [read post]
11 Jun 2023, 8:17 pm
Teva Pharmaceuticals USA, Inc. [read post]
25 Nov 2015, 9:59 pm
Teva Pharmaceuticals USA Inc., in a decision handed down earlier this month; the decision provides another example of the Court setting forth the contours of the scope of the... [read post]
26 Sep 2013, 9:33 pm
Teva Pharmaceuticals USA, Inc. [read post]
29 Jul 2013, 9:26 pm
This principle of patent law was reaffirmed by the Federal Circuit last week in Teva Pharmaceuticals USA, Inc. v. [read post]
20 Jan 2015, 9:28 pm
Teva Pharmaceuticals USA, Inc. v. [read post]
23 Dec 2021, 8:48 pm
One such decision arose earlier this month when the Federal Circuit affirmed a determination of non-obviousness by the Patent Trial and Appeal Board in an inter partes review proceeding, that opinion captioned Teva Pharmaceuticals USA, Inc. v. [read post]
10 Feb 2014, 7:01 pm
Teva Pharmaceuticals USA, Inc. was described as the end of the world by business interests when the Ninth Circuit held that attorneys could avoid CAFA removal by filing separate cases with fewer than 100 plaintiffs in each case to avoid the mass action provision in CAFA. [read post]
29 Sep 2014, 9:42 pm
Teva Pharmaceuticals USA, Inc. v. [read post]
22 Jan 2019, 7:48 am
Teva Pharmaceuticals USA, Inc. [read post]
6 Sep 2010, 9:48 pm
Teva Pharmaceuticals USA, Inc. [read post]
12 Oct 2010, 9:59 pm
§ 2201) in the Hatch-Waxman context in Teva Pharmaceuticals USA, Inc. v. [read post]
3 Jan 2015, 9:41 am
On January 20, 2015, the Supreme Court issued its decision in Teva Pharmaceuticals USA, Inc. v. [read post]
24 Feb 2009, 9:43 pm
Food and Drug Administration from approving the Abbreviated New Drug Application (ANDA) filed by Defendant-Appellant Teva Pharmaceuticals USA, Inc. [read post]
6 Aug 2014, 1:28 pm
Teva Pharmaceuticals USA, Inc. et al, the plaintiff alleged that metoclopramide, the generic name for Relgan, caused her to develop the neurologic condition known as tardive dyskinesia. [read post]
20 Jan 2015, 11:23 am
Teva Pharmaceuticals USA, Inc. v. [read post]
24 Feb 2022, 8:23 pm
Teva Pharmaceuticals USA, Inc., the panel majority affirming a District Court decision that the claimed invention was indeed obvious. [read post]
13 Aug 2020, 9:59 pm
Teva Pharmaceuticals USA, Inc., affirmed a District Court's finding that the asserted claims to a pharmaceutical formulation were indefinite. [read post]
20 Oct 2014, 12:09 pm
On October 15, 2014, the Supreme Court heard oral argument inTeva Pharmaceuticals USA, Inc. v. [read post]
30 Aug 2020, 10:19 am
According to DOJ’s press release: The United States has filed a False Claims Act complaint against Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. [read post]